Cosciens Biopharma Inc (CSCIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Sales | 304 | 269 | 96 | 242 | 102 |
| Gross Profit | 304 | 269 | 96 | 242 | 110 |
| Operating Expenses | 7,902 | 7,972 | 7,280 | 7,233 | 9,970 |
| Operating Income | -7,598 | -7,703 | -7,184 | -6,991 | -9,868 |
| Other Income | -622 | 1,648 | 176 | 3,315 | -182 |
| Pre-tax Income | -8,220 | -6,055 | -7,008 | -3,676 | -10,050 |
| Net Income Continuous | -8,220 | -6,055 | -7,008 | -3,676 | -10,043 |
| Net Income Discontinuous | N/A | N/A | N/A | N/A | 25 |
| Net Income | $-8,220 | $-6,055 | $-7,008 | $-3,676 | $-10,018 |
| EPS Basic Total Ops | -72.00 | -61.00 | -71.00 | -37.00 | -146.00 |
| EPS Basic Continuous Ops | -72.78 | -60.84 | -70.53 | -37.02 | -145.97 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | N/A | 0.36 |
| EPS Diluted Total Ops | -72.00 | -61.00 | -71.00 | -37.00 | -146.00 |
| EPS Diluted Continuous Ops | -72.78 | -60.84 | -70.53 | -37.02 | -137.58 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | N/A | 0.34 |
| EBITDA(a) | $-7,514 | $-7,836 | $-7,198 | $-6,993 | $-9,870 |